Prevalence of asthma and COPD in a cohort of patients at the follow up after COVID-19 pneumonia
- PMID: 35798643
- PMCID: PMC9186410
- DOI: 10.1016/j.pulmoe.2022.05.005
Prevalence of asthma and COPD in a cohort of patients at the follow up after COVID-19 pneumonia
Conflict of interest statement
Conflicts of interest There are no conflicts of interest.
References
-
- COVID-19 rapid guideline: managing the long-term effects of COVID-19 . NICE guideline; 2021. National Institute for Health and Care Excellence (NICE), Scottish Intercollegiate Guidelines Network (SIGN) and Royal College of General Practitioners (RCGP)https://www.nice.org.uk/guidance/ng188 [NG188] Published: 18 December 2020 Last updated: 11 November.
-
- Vestbo J, Hurd SS, Agustí AG, Jones PW, Vogelmeier C, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2013;187(4):347–365. - PubMed
-
- Global Initiative for Asthma. Global strategy for Asthma management and prevention, 2019. Available from www.ginasthma.org.